Kymera Therapeutics, Inc.
FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF

Abstract:

The present invention provides compounds, compositions thereof, and methods of using the same. The present invention also relates to compounds and methods useful for binding and modulating the activity of cereblon (CRBN), especially for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.